Zhongsheng Pharmaceutical announced that Guangdong Huanan Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for cefixime granules approved and issued by the State Drug Administration. The drug is a class 3 chemical, 50mg, suitable for various bacterial infectious diseases. It is considered a Class B medical insurance drug and included in the national essential drug catalogue. This approval is considered to have a positive impact on the company's anti-infective drug range. It is expected to have a positive impact on future performance, but it will not have a significant impact on current business performance. There is uncertainty about drug sales.

Zhongsheng Pharmaceutical announced that Guangdong Huanan Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for cefixime granules approved and issued by the State Drug Administration. The drug is a class 3 chemical, 50mg, suitable for various bacterial infectious diseases. It is considered a Class B medical insurance drug and included in the national essential drug catalogue. This approval is considered to have a positive impact on the company's anti-infective drug range. It is expected to have a positive impact on future performance, but it will not have a significant impact on current business performance. There is uncertainty about drug sales.